| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |